Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Market Commentary — 7976 total
This week brings a cluster of high-profile results. The action starts today, Sunday August 9, heading into Monday. Simon Property Group kicks off Monday. The mall giant reports Q2 2026 results after the close. It is…
Wall Street turned broadly constructive on Sunday, with target price upgrades dominating the latest analyst activity across healthcare, energy infrastructure, and real estate. ABBV led the positive revisions. The…
Short sellers ramped up positions across several names this week. SPCX — SpaceX's listed entity — saw the biggest move among large-caps. SI % of Free Float jumped 3.6 points to 36.4% in just seven days. Borrow costs…
Japan is grabbing the most attention right now. ETFs focused on Japan pulled in a net $14.0B over the past week. That is the largest single-geography inflow globally. Flow imbalance hit 79.1, signalling strong buying…
Earnings season is delivering sharp moves in both directions. Unity Software surged 36% after a Q2 beat. FIGS jumped 33% and Amplitude popped 27% — both catching shorts badly offside. Arhaus exploded 30% post-results,…
Options flow is tilting firmly bullish heading into a packed final stretch of earnings season. Across the market this week, calls dominated bets — and several individual names stand out. COGT drew 100% positive options…
Three major S&P 500 reports headline the next seven days, with semiconductor and networking giants set to move markets. Cisco Systems reports after Wednesday's close. The $479 billion networking leader carries a modest…
Analysts raised targets broadly on Friday, with upgrades spanning pharma, real estate, and financial services. ABBV led the healthcare moves. The average analyst target climbed to $273.86. AbbVie carries a market cap…
Insider selling dominated disclosures filed this week. Three stories stand out. NEXT plc CEO dumps £32M. Simon Wolfson, CEO of UK retailer NXT, filed yesterday that he sold $31.7M worth of shares on August 5. Executive…
HTZ is day two into a short squeeze. Bears are getting burned. Short interest sits at 65.4% of free float — but zero shares are available to borrow. Squeezed shorts have nowhere to hide. SOUN tells a similar story.…
HTZ remains the most extreme short position in the market. Short interest sits at 65.4% of free float. Zero shares are available to borrow. The stock is down 56% year-to-date. Options flow confirms the bearish…
Options flow this week splits sharply along sector lines. Pharma names are drawing bullish bets. Beaten-down names are pulling in put buyers. AMGN sits at an RSI of 72. That puts it in overbought territory ahead of its…
Analyst target price revisions dominated Friday's tape. Healthcare names drew the most upgrades while payments tech faced fresh selling pressure. ABBV led the healthcare moves. Analysts lifted the consensus target to…
Insider selling dominated filings this week, with some of America's most recognisable names quietly reducing their stakes. Charles Schwab, founder and co-chairman of SCHW, filed sales totalling over $37M in the past…
Short sellers have been busy this week. SPCX — Space Exploration Technologies — saw the sharpest surge among sizeable names. Its short interest as a % of free float jumped to 36.4%, up from just 3.7% a month ago.…
Japan is the standout story this week. ETFs focused on Japan pulled in a net $13.9B over seven days. That is the single largest geographic inflow of the week. A flow imbalance of 79.2 confirms strong buying pressure.…
This week is one of the busiest on the earnings calendar. Berkshire Hathaway released Q2 2026 results this morning. Cisco Systems reports Wednesday after the bell. Applied Materials closes the week on Thursday. Both…
Bearish options bets are piling into semiconductors this earnings week. Sandisk and Micron Technology top the US market in negative options volume over the past seven days. Both stocks have soared in 2026 — Sandisk up…
AbbVie leads today's analyst activity. The pharma giant's average target price rose to $273.86. That marks a fresh consensus high across 23 Buy-rated analysts. Amgen also drew upward revisions. Its average target…
A board member at ILMN dominated insider selling this week. Keith Meister, an asset management firm representative on the Illumina board, filed sales totalling $148M on August 6. He sold 741,127 shares across two days…
